CLIA Laboratory Citation Details
11D2025053
Survey Type: Standard
Survey Event ID: V3K911
Deficiency Tags: D0000 D2007 D6004
Summary Statement of Deficiencies D0000 A Clinical Laboratory Improvement Amendments (CLIA) Recertification survey was completed on November 09, 2021. The laboratory was not in compliance with applicable CLIA requirements found at 42 CFR 493.1 through 42 CFR 493.1780. The following deficiencies were cited: D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on review of the American Proficiency Institute (API) Proficiency Testing (PT) supplier documents, and staff interview, the laboratory was not rotating PT sample testing through the entire TP staff. Findings 1. Review of the API, PT attestation statements for the year 2020 and 2021, were signed by the same TP for all three events of 2020, and event one and two of 2021. 2. Staff interview with the laboratory manager, on 11/09/2021 at approximately 1 pm in the front office comfirmed the above aforementioned statement. D6004 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(a)(b) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (a) The laboratory director, if qualified, may perform the duties of the technical consultant, clinical consultant, and testing personnel, or delegate these responsibilities to personnel Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- meeting the qualifications of 493.1409, 493.1415, and 493.1421, respectively. (b) If the laboratory director reapportions performance of his or her responsibilities, he or she remains responsible for ensuring that all duties are properly performed. This STANDARD is not met as evidenced by: Based on review of the American Proficiency Institute (API) Proficiency Testing (PT) supplier documents, and staff interview, the Laboratory Director (LD) was not monitoring the PT sample testing was being rotated through the entire TP staff. Findings: 1. Review of the API PT attestation documents for all three events in 2020, and events one and two in 2021 showed that only one TP was performing the PT samples for evaluation. 2. Staff interview with the laboratory manager, on 11/09/2021 at approximately 1 pm in the front office comfirmed the above aforementioned statement. -- 2 of 2 --
Get full access to the detailed deficiency summary for this facility
Survey Type: Standard
Survey Event ID: C77Z11
Deficiency Tags: D0000 D5411 D5429 D6000 D6003 D6033 D6034 D6065
Summary Statement of Deficiencies D0000 A Clinical Laboratory Improvement Amendments (CLIA) Recertification survey was completed on July 22, 2019. The laboratory was not in compliance with applicable CLIA requirements found at 42 CFR 493.1 through 42 CFR 493.1780. The following condition/deficiencies were cited: D5411 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(a) Test systems must be selected by the laboratory. The testing must be performed following the manufacturer's instructions and in a manner that provides test results within the laboratory's stated performance specifications for each test system as determined under 493.1253. This STANDARD is not met as evidenced by: Based on review of a procedural change for determining Rh factor with Albaclone reagents, review of the reagent package insert, review of the patient logs(with temperature documents at the bottom), and staff interview, the laboratory was not following the manufacturer's specifications for the room temperature during test performance. Findings: 1. Review of the procedural change for determining the Rh factor of the sample, stated "if no agglutination occurs, incubate the test for five minutes at 18-24 degrees Celsius (64.4 to 75.2 degrees Fahrenheit)." 2. Review of the package insert for the Albaclone Rh factor reagent, states "incubate the slide for 5 minutes at 20 - 24 degrees Celsius (68 to 75.2 degrees Fahrenheit)." 3. Review of the Patient logs, the room temperature range was listed as 18 to 24 degrees Celsius, but according to manufacturer's specifications the temperature range should have been 20 to 24 degrees Celsius. 4. Interview with staff #1 (CMS 209 form) on July 22, 2019, at approximately 3pm, in the Consultation Room, confirmed the aforementioned statements. D5429 MAINTENANCE AND FUNCTION CHECKS Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 5 -- CFR(s): 493.1254(a)(1) For unmodified manufacturer's equipment, instruments, or test systems, the laboratory must perform and document maintenance as defined by the manufacturer and with at least the frequency specified by the manufacturer. This STANDARD is not met as evidenced by: Based on review of the maintenance documents and staff interview, the laboratory did not have any documentation of maintenance on the Adams MicroHematocrit II centrifuge. Findings: 1. Upon observation during the lab tour, the Adams MicroHematocrit II (MHCTII) had a sticker that indicated the voltage and amps had been checked. 2. Review of maintenance documents confirmed that there was no documentation of timer or speed (RPM) checks performed on the MHCTII. 3. Interview with staff #1 (CMS 209 form), on July 22, 2019, at approximately 12:20 pm, in the Consultation Office, confirmed that the timer checks and RPM had not been checked on the MHCTII centrifuge. D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on review of personnel records and staff interview, the laboratory director (LD) failed to meet the qualification requirements during the time period of August 1, 2018 to July 22, 2019. Findings include: Refer to D6003 for details D6003 LABORATORY DIRECTOR QUALIFICATIONS CFR(s): 493.1405 AND 493.1406 The laboratory director must be qualified to manage and direct the laboratory personnel and the performance of moderate complexity tests and must be eligible to be an operator of a laboratory within the requirements of subpart R of this part. (a) The laboratory director must possess a current license as a laboratory director issued by the State in which the laboratory is located, if such licensing is required; and (b) The laboratory director must-- (b)(1)(i) Be a doctor of medicine or doctor of osteopathy licensed to practice medicine or osteopathy in the State in which the laboratory is located; and (b)(1)(ii) Be certified in anatomic or clinical pathology, or both, by the American Board of Pathology or the American Osteopathic Board of Pathology or possess qualifications that are equivalent to those required for such certification; or (b)(2)(i) Be a doctor of medicine, doctor of osteopathy, or doctor of podiatric medicine licensed to practice medicine, osteopathy, or podiatry in the State in which the Laboratory is located; and (b)(2)(ii) Have had laboratory training or experience consisting of: (b)(2)(ii)(A) At least one year directing or supervising non- waived laboratory testing; or (b)(2)(ii)(B) Beginning September 1, 1993, have at least 20 continuing medical education credit hours in laboratory practice commensurate with the director responsibilities defined in 493.1407; or (b)(2)(ii)(C) Laboratory training equivalent to paragraph (b)(2)(ii)(B) of this section obtained during medical residency. (For example, physicians certified either in hematology or hematology and -- 2 of 5 -- medical oncology by the American Board of Internal Medicine); or (b)(3) Hold an earned doctoral degree in a chemical, physical, biological, or clinical laboratory science from an accredited institution; and (b)(3)(i) Be certified by the American Board of Medical Microbiology, the American Board of Clinical Chemistry, the American Board of Bioanalysis, or the American Board of Medical Laboratory Immunology; or (b)(3)(ii) Have had at least one year experience directing or supervising non-waived laboratory testing; (b)(4)(i) Have earned a master's degree in a chemical, physical, biological or clinical laboratory science or medical technology from an accredited institution; (b)(4)(ii) Have at least one year of laboratory training or experience, or both in non-waived testing; and (b)(4)(iii) In addition, have at least one year of supervisory laboratory experience in non-waived testing; or (b)(5)(i) Have earned a bachelor's degree in a chemical, physical, or biological science or medical technology from an accredited institution; (b)(5)(ii) Have at least 2 years of laboratory training or experience, or both in non-waived testing; and (b)(5)(iii) In addition, have at least 2 years of supervisory laboratory experience in non-waived testing; (b)(6) Be serving as a laboratory director and must have previously qualified or could have qualified as a laboratory director under 493.1406; or (b)(7) On or before February 28, 1992, qualified under State law to direct a laboratory in the State in which the laboratory is located. Laboratory director qualifications on or before February 28, 1992 The laboratory director must be qualified to manage and direct the laboratory personnel and test performance. (a) The laboratory director must possess a current license as a laboratory director issued by the State, if such licensing exists; and (b) The laboratory director must: (b)(1) Be a physician certified in anatomical or clinical pathology (or both) by the American Board of Pathology or the American Osteopathic Board of Pathology or possess qualifications that are equivalent to those required for such certification; (b)(2) Be a physician who: (b)(2)(i) Is certified by the American Board of Pathology or the American Osteopathic Board of Pathology in at least one of the laboratory specialties; or (b)(2)(ii) Is certified by the American Board of Medical Microbiology, the American Board of Clinical Chemistry, the American Board of Bioanalysis, or other national accrediting board in one of the laboratory specialties; or (b)(2)(iii) Is certified by the American Society of Cytology to practice cytopathology or possesses qualifications that are equivalent to those required for such certification; or (b)(2)(iv) Subsequent to graduation, has had 4 or more years of full-time general laboratory training and experience of which at least 2 years were spent acquiring proficiency in one of the laboratory specialties; (b)(3) For the subspecialty of oral pathology only, be certified by the American Board of Oral Pathology, American Board of Pathology or the American Osteopathic Board of Pathology or possesses qualifications that are equivalent to those required for certification; (b)(4) Hold an earned doctoral degree from an accredited institution with a chemical, physical, or biological science as a major subject and (b)(4)(i) Is certified by the American Board of Medical Microbiology, the American Board of Clinical Chemistry, the American Board of Bioanalysis, or other national accrediting board acceptable to HHS in one of the laboratory specialties; or (b)(4)(ii) Subsequent to graduation, has had 4 or more years of full-time general laboratory training and experience of which at least 2 years were spent acquiring proficiency in one of the laboratory specialties; (b)(5) With respect to individuals first qualifying before July 1, 1971, have been responsible for the direction of a laboratory for 12 months between July 1, 1961, and January 1, 1968, and, in addition, either: (b)(5)(i) Was a physician and subsequent to graduation had at least 4 years of pertinent full-time laboratory experience; (b)(5)(ii) Held a master's degree from an accredited institution with a chemical, physical, or biological science as a major subject and subsequent to graduation had at least 4 years of pertinent full- time laboratory experience; (b)(5)(iii) Held a bachelor's degree from an accredited institution with a chemical, physical, or biological science as a major subject and -- 3 of 5 -- subsequent to graduation had at least 6 years of pertinent full-time laboratory experience; or (b)(5)(iv) Achieved a satisfactory grade through an examination conducted by or under the sponsorship of the U.S. Public Health Service on or before July 1, 1970; or (b)(6) Qualify under State law to direct the laboratory in the State in which the laboratory is located. Note: The January 1, 1968 date for meeting the 12 months' laboratory direction requirement in paragraph (b)(5) of this section may be extended 1 year for each year of full-time laboratory experience obtained before January 1, 1958 required by State law for a laboratory director license. An exception to the July 1, 1971 qualifying date in paragraph (b)(5) of this section was made provided that the individual requested qualification approval by October 21, 1975 and had been employed in a laboratory for at least 3 years of the 5 years preceding the date of submission of his qualifications. This STANDARD is not met as evidenced by: Based on review of personnel records and staff interview, the laboratory director (LD) failed to meet the qualification requirements during the time period of August 1, 2018 to July 22, 2019. Findings include: 1. Review of personnel records (08/01/2018 to 07 /22/2019) revealed the LD did not have the proper lab training or experience required to direct a moderate complexity lab. 2. Interview with staff #1(CMS 209 form) on 9/19 /18 at approximately 10:30 AM in the breakroom, confirmed the lab director did not meet the training or experience requirements D6033 TECHNICAL CONSULTANT-MODERATE COMPEXITY CFR(s): 493.1409 The laboratory must have a technical consultant who meets the qualification requirements of 493.1411 of this subpart and provides technical oversight in accordance with 493.1413 of this subpart. This CONDITION is not met as evidenced by: Based on review of personnel records and staff interview, the Technical Consultant (TC) failed to meet the qualification requirements during the time period of August 1, 2018 to July 22, 2019. Findings include: Refer to D6034 for details D6034 TECHNICAL CONSULTANT QUALIFICATIONS CFR(s): 493.1411 The laboratory must employ one or more individuals who are qualified by education and either training or experience to provide technical consultation for each of the specialties and subspecialties of service in which the laboratory performs moderate complexity tests or procedures. The director of a laboratory performing moderate complexity testing may function as the technical consultant provided he or she meets the qualifications specified in this section. This STANDARD is not met as evidenced by: Based on review of personnel records and staff interview, the Technical Consultant (TC) failed to meet the qualification requirements during the time period of August 1, 2018 to July 22, 2019. Findings include: 1. Review of personnel records (08/01/2018 to 07/22/2019) revealed the TC did not have the proper lab training or experience required to direct a moderate complexity lab. 2. Interview with staff #1(CMS 209 -- 4 of 5 -- form) on 9/19/18 at approximately 10:30 AM in the breakroom, confirmed the TC did not meet the training or experience requirements D6065 TESTING PERSONNEL QUALIFICATIONS CFR(s): 493.1423(b)(1)(2)(3)(4)(i) (b) Meet one of the following requirements: (b)(1) Be a doctor of medicine or doctor of osteopathy licensed to practice medicine or osteopathy in the State in which the laboratory is located or have earned a doctoral, master's, or bachelor's degree in a chemical, physical, biological or clinical laboratory science, or medical technology from an accredited institution; or (b)(2) Have earned an associate degree in a chemical, physical or biological science or medical laboratory technology from an accredited institution; or (b)(3) Be a high school graduate or equivalent and have successfully completed an official military medical laboratory procedures course of at least 50 weeks duration and have held the military enlisted occupational specialty of Medical Laboratory Specialist (Laboratory Technician); or (b)(4)(i) Have earned a high school diploma or equivalent; and This STANDARD is not met as evidenced by: Based on review of the Employee documents and staff interview, there was a staff member listed as a Testing Personnel (TP) that did not provide a copy of a high school diploma, or equivalency. Findings: 1 Based on review of the employee documents, staff member #1 (CMS-209), did not have a copy of a high school diploma or equivalency, required for moderate complexity testing personnel. 2 Interview with staff #1 (CMS-209) on July 22, 2019, at approximately 3pm, in the Consultation Room, confirmed that the aforementioned staff member did not have a copy of a high school diploma or equivalency. -- 5 of 5 --
Get full access to the detailed deficiency summary for this facility